Ipsen (XTER:I7G) Forward Dividend Yield % : 0.00% (As of Jun. 17, 2024)

View and export this data going back to 2005. Start your Free Trial

What is Ipsen Forward Dividend Yield %?

As of today (2024-06-17), the Forward Annual Dividend Yield of Ipsen is 0.00%.

As of today (2024-06-17), the Trailing Annual Dividend Yield of Ipsen is 0.00%.

XTER:I7G's Forward Dividend Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.93
* Ranked among companies with meaningful Forward Dividend Yield % only.

Ipsen's Dividends per Share for the six months ended in Dec. 2023 was €0.00.

During the past 3 years, the average Dividends Per Share Growth Rate was 6.30% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 4.30% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 4.30% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Ipsen was 7.70% per year. The lowest was 2.00% per year. And the median was 5.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Ipsen's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Ipsen's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ipsen's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipsen's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Ipsen's Forward Dividend Yield % falls into.

Ipsen Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Ipsen (XTER:I7G) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Ipsen Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Ipsen's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipsen (XTER:I7G) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (XTER:I7G) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

IPSEY:USA IPSEF:USA 0MH6:UK IPN:France I7G:Germany

Address

65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100

Website

https://www.ipsen.com

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.

Ipsen (XTER:I7G) Headlines

No Headlines